» Articles » PMID: 36005157

Therapy Failure and Resistance Mechanism in Eyelid and Ocular Surface Tumors

Overview
Journal Neurosignals
Specialties Cell Biology
Neurology
Date 2022 Aug 25
PMID 36005157
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant tumors of the eyelids and ocular surface are common ocular malignancies. At present, surgical treatment is mostly the first choice for these types of tumors. However, postoperative tumor recurrence and metastasis are still regarded as failures in the treatment of such malignancies. Based on this, malignant tumors of the eyelid and ocular surface are sometimes accompanied by local adjuvant chemotherapy and systemic chemotherapy to treat patients with relapse, invasion of adjacent tissues, and systemic metastases. Still, drug resistance greatly affects the treatment effect. This review lists several mechanisms of recurrence and metastasis of ocular surface and eyelid tumors after surgery, as well as mechanisms that may lead to non-surgical treatment or drug resistance.

Citing Articles

Global research trends in the treatment of squamous cell carcinoma over the past decade: A bibliometric analysis.

Li X, Rokohl A, Ju X, Guo Y, Hou X, Fan W Adv Ophthalmol Pract Res. 2024; 4(4):209-215.

PMID: 39484053 PMC: 11526077. DOI: 10.1016/j.aopr.2024.08.001.


Personalized treatment concepts in extraocular cancer.

Ju S, Rokohl A, Guo Y, Yao K, Fan W, Heindl L Adv Ophthalmol Pract Res. 2024; 4(2):69-77.

PMID: 38590555 PMC: 10999489. DOI: 10.1016/j.aopr.2024.02.003.


Topical and Intralesional Immunotherapy for the Management of Skin Cancer in Special Locations: Lips and Eyelids.

Bujan Bonino C, Rodriguez-Blanco I, Sanchez-Aguilar Rojas D, Vazquez Veiga H, Florez A Cancers (Basel). 2023; 15(20).

PMID: 37894385 PMC: 10604909. DOI: 10.3390/cancers15205018.